Live Chat
Yashoda Hospitals > Doctors > Radiation Oncology > Dr. K. Kiran Kumar
Dr. K. Kiran Kumar

Dr. K. Kiran Kumar

MD, DNB (Radiation Therapy)

Department: Radiation Oncology Exp: 18 yrs

Designation: Sr. Consultant Radiation Oncologist

Languages:
English, Hindi, Telugu
Med Reg No:
46981

Day time OPD:
MON - SAT : 12:00 PM - 04:00 PM

Location:
Hitec CitySomajiguda

About the Doctor

Dr. K. Kiran Kumar is a Consultant Radiation Oncologist at Yashoda Hospitals, Somajiguda, with over 15 years of experience.

Educational Qualifications

  • MD, DNB (Radiation Therapy)

Experience

  • 2008-Present: Consultant Radiation Oncologist, Yashoda Hospitals, Somajiguda
  • 2007-2008: Registrar, Department of Radiation Oncology

Services offered

  • Brachytherapy (Internal Radiation Therapy)
  • External Beam Radiation for Prostate Cancer
  • Radiation Oncology
  • Advanced Techniques (SBRT, IMRT, IGRT)
  • Cancer Screening (Preventive)
  • SBRT/SABR (Stereotactic Body Radiotherapy) for Cancerous Tumours
  • Stereotactic Radiosurgery (SRS) for Brain & Spine Tumours
  • External Beam Radiotherapy (EBRT)
  • Image Guided Radiotherapy (IGRT)
  • Teleradiotherapy
  • Accelerated Partial Breast Radiotherapy
  • Hormone Therapy for Breast Cancer
  • Hormone Therapy for Prostate Cancer
  • Pap Smear

Special Interest and Expertise

  • Rapid Arc Technique/SRS/SRT

Select preferred date and time to continue to book an appointment

Sat 18 Jan
Sun
Mon 20 Jan
Tue 21 Jan
Wed 22 Jan
Thu 23 Jan
Fri 24 Jan
Sat 25 Jan
Sun
Mon 27 Jan
Tue 28 Jan
Wed 29 Jan
Thu 30 Jan
Fri 31 Jan
Sat 01 Feb
Sun
Mon 03 Feb
Tue 04 Feb
Wed 05 Feb
Thu 06 Feb
Fri 07 Feb
Sat 08 Feb
Sun
Mon 10 Feb
Tue 11 Feb
Wed 12 Feb
Thu 13 Feb
Fri 14 Feb
Sat 15 Feb
Sun
Mon 17 Feb
  • ARIO
  • IMA
  • ESMO
  • Principal Investigator in Trial no 1200.161, Trial title-A randomized, open-label, phase III study to evaluate the efficacy and safety of oral afatinib versus intravenous methotrexate in patients with recurrent and/or metastatic head and neck squamous cell carcinoma who have progressed after platinum-based therapy
  • Principal Investigator trial number: 1200:131 Trial title-LUX-Head and Neck 2: randomised, double blind, placebo-controlled, phase III study to evaluate the efficacy and safety of afatinib as adjuvant therapy after chemo-radiotherapy in primary unresected patients with stage III, IVa, or IVb loco-regionally advanced head and neck squamous cell carcinoma
  • Title: P276-00/64/11 “A Multicenter, Phase II/III study to assess radiation induced mucositis in subjects with locally advanced squamous cell carcinoma of the head and neck, administered cisplatin and radiation with or without P276-00
  • Title NETU08-18: A phase III multicenter, randomized, double-blind, double-dummy, active-controlled, parallel group study of the efficacy and safety of oral netupitant administered in combination with palonosetron and dexamethasone compared to oral palonosetron and dexamethasone for the prevention of nausea and vomiting in cancer patients receiving moderately emetogenic chemotherapy
  • Title: PALO10-01: Single dose, multicenter, randomized, double-blind, double-dummy, parallel group study to assess the efficacy and safety of oral palonosetron 0.50 mg compared to I.V palonosetron 0.25mg administered with dexamthasone for the prevention of chemotherapy-induced nausea and vomiting in cancer patients receiving highly emetogenic cisplatin-based chemotherapy

Media

Is cancer infectious - Dr K Kiran Kumar Radiation Oncologist

Is-cancer-infectious-Dr-K-Kiran-Kumar-Radiation-Oncologist

Bariatric-Surgery-for-weight-loss-Dr-Manisegaran

Blogs by Dr. K. Kiran Kumar

Revolutionizing Cancer Treatment: Next-Gen Radiation Therapies

Testimonial for Dr. K. Kiran Kumar

Mr. Abdul Shafie

Procedure:
Patient Location: Sudan

I am facing problems with mycosis fungoides and it affected my skin, the rash...

Read more

Case Studies by Dr. K. Kiran Kumar

TSEBT-casestudy1

Successful Treatment of Cutaneous T-Cell Lymphoma with Total Skin Electron Beam Therapy (TSEBT)